Jan 29, 2026 01:37AM
Oct 30, 2025 03:04AM
Jul 30, 2025 02:41AM
May 8, 2025 02:36AM
Jan 30, 2025 01:35AM
Oct 31, 2024 02:05AM
Jul 31, 2024 02:06AM Takeda Announces First Quarter FY2024 Results - Strong Performance by Growth & Launch Products; Advancements in Promising Late-Stage Pipeline
May 9, 2024 02:07AM
Feb 1, 2024 01:02AM
Oct 26, 2023 02:00AM
Jul 27, 2023 02:00AM
May 11, 2023 02:40AM
Feb 2, 2023 05:40AM
Feb 2, 2023 01:00AM Takeda Reinforces Long-term Growth Through Pipeline Advancement and Two Targeted Acquisitions; Delivers Another Strong Quarter in FY2022 Q3
Oct 27, 2022 02:00AM
Jul 28, 2022 02:00AM
Jun 5, 2022 08:00AM
May 11, 2022 02:15AM
Feb 3, 2022 05:42AM
Feb 3, 2022 01:13AM
Oct 28, 2021 05:50AM Takeda Pharmaceutical Co. Ltd. (TAK) Announces Up to YEN 100B Share Buyback
Oct 28, 2021 03:01AM
Oct 28, 2021 02:15AM
Jul 30, 2021 02:00AM
May 11, 2021 02:35AM
Feb 4, 2021 01:00AM
Jan 11, 2021 05:20PM
Oct 29, 2020 02:19AM Takeda FY2020 H1 Results Demonstrate Portfolio Resilience; Confirms Full-Year Management Guidance & Raises Forecasts for Free Cash Flow, Reported OP & Reported EPS
Jul 31, 2020 03:55AM
May 13, 2020 02:00AM
Feb 4, 2020 01:00AM
Jan 14, 2020 06:00AM
Oct 31, 2019 02:00AM
Jul 31, 2019 02:00AM
May 14, 2019 02:00AM Takeda Reports FY2018 Full Year Results and Issues FY2019 Guidance

436,668 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All